ClinicalTrials.Veeva

Menu

MSCs For Treatment of Azoospermic Patients

A

Al-Azhar University

Status and phase

Completed
Phase 2
Phase 1

Conditions

Male Infertility

Treatments

Biological: Stem Cells

Study type

Interventional

Funder types

Other

Identifiers

NCT02025270
AZH010066099
Azhar23052011 (Other Grant/Funding Number)

Details and patient eligibility

About

In this study, we performed autologous BMDMSC transplantation to the testis of Azoospermic patients in a trial to enhance and activate the spermatogonial stem cells of the testis and aiming to produce motile sperm.

Full description

Bone marrow aspirated and stem cells were isolated, cultured and characterized using flow cytometer. Stem cells prepared according to GMP regulations then injected into rete testis using special syringe. Patients follow up will carried out for a year , three month interval. FSH, testosterone, testicular size as well as sexual potency will assessed every three months.

Enrollment

100 estimated patients

Sex

Male

Ages

20 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All Non obstructive Azoospermic Patients.
  • Azoospermic Patients due to Administration of Chemo/Radiotherapy.

Exclusion criteria

  • Patients with Testicular Cancer.
  • Patients with Complete Deletion of Chromosome Y AZF (a,b,c) Regions.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

100 participants in 1 patient group

Laboratory and Clinical
Other group
Description:
60 ml of Bone marrow will aspirated for stem cells isolation and preparation. 5 ml of stem cells prepared according to GMP rules injected into rete testis.
Treatment:
Biological: Stem Cells

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems